Abstract
Emodin reverses sorafenib resistance in hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition via the Akt signaling pathway
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have